Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUBG.L Regulatory News (UBG)

  • There is currently no data for UBG

Response to press speculation

12 Jul 2023 12:13

RNS Number : 8204F
Unbound Group PLC
12 July 2023
ย 

12 July 2023

ย 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

Unbound Group plc

("Unbound", the "Company" or the "Group")

Response to press speculation

The Board notes recent press speculation regarding possible administration of the Group as one of a number of options that the Company is considering. Consistent with the strategic review initiated by the Board and previous announcements, the Board and the Company's advisers continue to explore options for the Group and its shareholders, which include a formal restructuring plan and equity raise. In the event that such discussions prove unsuccessful, it is likely that administration would occur, in which case the Company's ordinary shares would be suspended from trading on AIM.

The Board will continue to provide further updates as appropriate.

ย 

Enquiries

ย 

Unbound Group plc

Ian Watson, CEO

Gavin Manson, CFO

c/o Alma PR

ย 

Singer Capital Markets (Financial Adviser, Nominated Adviser & Broker)

Peter Steel / Tom Salvesen / Alaina Wong / James Fischer

+44 (0)20 7496 3000

Interpath Advisory Ltd (Joint Financial Adviser)

Will Wright / Andrew Stone / Jack Brazier

+44 (0)20 3989 2800

Alma PR Limited (Financial PR)

Josh Royston / Sam Modlin / Hannah Campbell

+44 (0)20 3405 0205

unbound@almapr.co.uk

ย 

Important Information

This announcement (including any information incorporated by reference in this announcement) contains statements about the Group that are or may be deemed to be forward looking statements. Without limitation, any statements preceded by or followed by or that includes the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or words or terms of similar substance of the negative thereof, may be forward looking statements.

ย 

These forward looking statements are not guarantees of future performance. Such forward looking statements involve known and unknown risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward looking statement. Due to such uncertainties and risks, readers should not rely on such forward looking statements, which speak only as of the date of this announcement, except as required by applicable law.

ย 

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities laws of such jurisdictions.

ย 

Market Abuse Regulation

The information contained within this announcement would have, prior to its release, constituted inside information as stipulated under Article 7 of the Market Abuse Regulation (EU) No.596/2014 as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019 ("UK MAR"). Upon the publication of this announcement via a regulatory information service, this inside information will be considered to be in the public domain. For the purposes of UK MAR, the person responsible for arranging for the release of this information on behalf of Unbound is Gavin Manson.

ย 

ย 

ย 

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
SPCGZGMNMZLGFZM
Date   Source Headline
2nd Feb 20233:02 pmRNSHolding(s) in Company
2nd Feb 20233:00 pmRNSHolding(s) in Company
20th Jan 20237:00 amRNSDirector/PDMR Shareholding
19th Jan 20234:00 pmRNSDirector/PDMR Shareholding
17th Jan 20239:05 amRNSSecond Price Monitoring Extn
17th Jan 20239:00 amRNSPrice Monitoring Extension
17th Jan 20238:30 amRNSTrading Update and Operating Review - Replacement
17th Jan 20237:00 amRNSTrading Update and Operating Review
1st Dec 20227:00 amRNSBoard Changes
20th Sep 20227:00 amRNSInterim results for the six months to 31 July 2022
6th Sep 20227:00 amRNSDirectorate Change
1st Sep 20224:12 pmRNSTotal Voting Rights
12th Aug 20225:21 pmRNSHolding(s) in Company
11th Aug 20223:56 pmRNSHolding(s) in Company
11th Aug 20222:00 pmRNSDirector/PDMR Shareholding
10th Aug 202210:25 amRNSResult of General Meeting and Open Offer
28th Jul 20229:31 amRNSInitial launch of curated multi-brand platform
28th Jul 20227:00 amRNSInitial launch of curated multi-brand platform
22nd Jul 20225:35 pmRNSOpen Offer Launch, Posting of Circular & GM Notice
22nd Jul 202211:03 amRNSResult of Placing and Subscription
22nd Jul 20229:05 amRNSSecond Price Monitoring Extn
22nd Jul 20229:00 amRNSPrice Monitoring Extension
22nd Jul 20227:00 amRNSClose of Accelerated Bookbuild
21st Jul 20224:35 pmRNSProposed Fundraising
30th Jun 20227:00 amRNSTrading Update & Change of Nomad
18th May 20225:51 pmRNSDirector/PDMR Shareholding
12th May 20223:39 pmRNSResult of AGM
12th May 20227:00 amRNSTrading and Partnership Strategy Update
6th May 20227:00 amRNSDisposal of property asset
7th Apr 20224:51 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20229:38 amRNSDirector/PDMR Shareholding; grant of share awards
9th Mar 20222:58 pmRNSHolding(s) in Company
9th Mar 20222:44 pmRNSDirector/PDMR Shareholding
4th Mar 20229:39 amRNSDirector/PDMR Shareholding
3rd Mar 20227:07 amRNSFinal Results
17th Feb 20227:00 amRNSTrading Update Hotter Shoes; Partnership with M&S
7th Feb 20226:01 pmRNSDirector/PDMR Shareholding
7th Feb 20228:49 amEQSUnbound Group (UBG): Initiation - A platform for growth
1st Feb 20228:29 amRNSTotal Voting Rights
1st Feb 20227:00 amRNSAdmission to Trading on AIM
27th Jan 202210:00 amRNSSchedule One Update - Unbound Group PLC
27th Jan 20227:00 amRNSPublication of Admission Document
25th Jan 20225:51 pmRNSHolding(s) in Company
25th Jan 20225:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.